We are live on ! Find out more
ONC

BeOne Medicines Ltd
ONC

222 hedge funds and large institutions have $7.2B invested in BeOne Medicines Ltd in 2022 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 73 increasing their positions, 78 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

333% more call options, than puts

Call options by funds: $12.1M | Put options by funds: $2.79M

0% more funds holding in top 10

Funds holding in top 10: 9 → 9 (0)

0.02% less ownership

Funds ownership: 3.99% → 3.97% (-0.02%)

6% less repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 78

5% less funds holding

Funds holding: 234 → 222 (-12)

17% less capital invested

Capital invested by funds: $8.65B → $7.2B (-$1.45B)

28% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 36

Holders
222
Holders Change
-12
Holders Change %
-5.13%
% of All Funds
3.82%
Holding in Top 10
9
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
26
Increased
73
Reduced
78
Closed
36
Calls
$12.1M
Puts
$2.79M
Net Calls
+$9.3M
Net Calls Change
+$2.34M

Top Buyers

1
Primecap Management
Primecap Management
California
+$121M
2
Temasek Holdings
Temasek Holdings
Singapore
+$24.6M
3
APM
Avidity Partners Management
Texas
+$22.7M
4
TCM
Tang Capital Management
California
+$18M
5
Invesco
Invesco
Georgia
+$13.8M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$49.2M
2
Capital International Investors
Capital International Investors
California
-$36.6M
3
California Public Employees Retirement System
California Public Employees Retirement System
California
-$17.8M
4
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board
Ontario, Canada
-$13.9M
5
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
-$13.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
HI
201
Harbour Investments
Wisconsin
$5K – – –
National Bank of Canada
202
National Bank of Canada
Quebec, Canada
$4K -$1.2K -7 -18%
S
203
SignatureFD
Georgia
$4K -$343 -2 -7%
Carson Wealth (CWM LLC)
204
Carson Wealth (CWM LLC)
Nebraska
$4K +$4.12K +24 +267%
EWA
205
EverSource Wealth Advisors
Alabama
$3K +$687 +4 +24%
FRA
206
Front Row Advisors
California
$2K -$343 -2 -12%
TJHA
207
Thomas J. Herzfeld Advisors
Florida
$2K – – –
TWC
208
TD Waterhouse Canada
Ontario, Canada
$1.25K – – –
CFGS
209
Concourse Financial Group Securities
Alabama
$1K -$515 -3 -38%
AAP
210
Arax Advisory Partners
Colorado
$1K – – –
EBA
211
Eagle Bay Advisors
New York
$1K – – –
GRP
212
Global Retirement Partners
California
$1K – – –
QC
213
Quent Capital
New York
$1K – – –
Fifth Third Bancorp
214
Fifth Third Bancorp
Ohio
$1K +$515 +3 +100%
JWA
215
JFS Wealth Advisors
Pennsylvania
$1K +$859 +5 New
California Public Employees Retirement System
216
California Public Employees Retirement System
California
– -$17.8M -110,059 Closed
OMC
217
Old Mission Capital
Illinois
– -$11.1M -68,336 Closed
Qube Research & Technologies (QRT)
218
Qube Research & Technologies (QRT)
United Kingdom
– -$5.6M -34,589 Closed
HT
219
HAP Trading
New York
– -$3.44M -21,243 Closed
CFM
220
Capricorn Fund Managers
United Kingdom
– -$3.21M -19,800 Closed
PCIG
221
Partners Capital Investment Group
Massachusetts
– -$2.96M -18,311 Closed
Jane Street
222
Jane Street
New York
– -$2.37M -13,802 Closed
LP
223
LMR Partners
United Kingdom
– -$2.12M -13,108 Closed
VF
224
Virtu Financial
New York
– -$1.58M -9,758 Closed
SSA
225
Schonfeld Strategic Advisors
New York
– -$1.25M -7,699 Closed
7 8
9
10 11

ONC Hedge Fund Activity: Q3 2022 in Review

222 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q3 2022, worth a combined $7.2B — down 17% from $8.65B a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of ONC and 26 opened new positions — a net loss of 10 holders — while 78 trimmed existing stakes and 73 added.

The largest buyer was Primecap Management, adding an estimated $121M. The largest seller was Fidelity Investments, cutting an estimated $49.2M.

  • 222 institutional investors held BeOne Medicines Ltd (ONC) as of Q3 2022, down from 234 in Q2 2022.
  • Funds reported $7.2B of BeOne Medicines Ltd stock for Q3 2022, down 17% quarter-over-quarter.
  • 26 funds opened new BeOne Medicines Ltd positions in Q3 2022 and 36 closed out, a net change of -10 holders.
  • The largest BeOne Medicines Ltd buyer in Q3 2022 was Primecap Management, an estimated $121M added.
  • The largest BeOne Medicines Ltd seller in Q3 2022 was Fidelity Investments, an estimated $49.2M sold.

Based on aggregated 13F filings for Q3 2022.